Skip to main content
logo
Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
56.58
+1.11 (2.00%)
At close: Jul 21, 2026, 4:00 PM EDT
56.60
+0.02 (0.04%)
After-hours: Jul 21, 2026, 4:55 PM EDT

Travere Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
5,2623,4741,5236781,3521,940
Market Cap Growth
267.79%128.05%124.84%-49.89%-30.30%36.22%
Enterprise Value
5,2893,4801,554515.481,3091,649
Last Close Price
56.5838.2117.428.9921.0331.04
Forward PE
23.9838.0842.8542.8542.8542.85
PEG Ratio
-2.202.202.202.202.20
PS Ratio
9.757.086.534.6712.3514.71
PB Ratio
51.9230.2625.793.3731.556.42
P/TBV Ratio
-3550.82-6.93-12.09
P/FCF Ratio
131.9391.95----
P/OCF Ratio
131.9391.95----
EV/Sales Ratio
9.867.096.673.5511.9612.51
EV/FCF Ratio
133.5292.11----
Debt / Equity Ratio
3.262.815.541.999.410.85
Debt / EBITDA Ratio
20.36-----
Debt / FCF Ratio
8.278.70----
Net Debt / Equity Ratio
0.640.050.52-0.81-1.00-0.96
Net Debt / EBITDA Ratio
3.91-2.85-0.110.460.141.56
Net Debt / FCF Ratio
1.590.16-0.130.580.2314.62
Asset Turnover
0.920.820.340.200.150.19
Inventory Turnover
0.250.310.230.640.750.51
Quick Ratio
2.812.521.983.313.284.58
Current Ratio
3.132.742.083.473.424.70
Return on Equity (ROE)
-34.75%-57.80%-246.75%-308.90%-192.18%-84.66%
Return on Assets (ROA)
-9.81%-10.69%-46.85%-53.15%-44.18%-28.87%
Return on Invested Capital (ROIC)
-40.31%-60.82%-503.40%-1999.99%-5660.75%-381.04%
Return on Capital Employed (ROCE)
-13.04%-14.98%-64.48%-68.01%-54.07%-34.17%
FCF Yield
0.76%1.09%----
Buyback Yield / Dilution
-10.28%-13.09%-6.22%-16.48%-6.56%-25.86%
Total Shareholder Return
-10.28%-13.09%-6.22%-16.48%-6.56%-25.86%
SEC Filings: 10-K · 10-Q